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HEART FAILURE -- 
Improvement of Exercise Capacity With Treatment of Cheyne-Stokes 
Respiration in Patients With Congestive Heart Failure 
&s&r. Piti, %mal oxygen signiticantty r&wed the duratioa of 
Cbeyne-Stokes respiratioa (1Qt 2 142 vs. 88 = 105 ado [mean f 
SD]; p c 0.W). Sieep improved as evtdeaced by less stage 1 steep 
aad fewer arousals (20 f 13 vs. 15 i: 9/b total steep tiaw p C 
0.05) as well as more stage 2 and slow-wave sleep; noctunml 
oxygen sahuatlon also improved. Peak oxygea amsmnptioa dar- 
iagexercisete!5tiQiweasedafteroxygeetreatment(83§+395 
vs. 960 k 389 ebnh~; p c 0.05). Cagaitive fanctioa evalaated by 
tbe trail-makbrg test improvrd, but daytime symptoms io the 
beattb assessosenl ebart did not improve significantiy. 
CoReBrsioRs. Sttccessfnl treahwot of Cbeyae-Stokes respira- 
tioo with mx&raal mual oxygen imprtwes aot only sleep, but also 
exe&e tokance and cof@ive faoetioo ia patients with wages- 
Live beari failare. 
(J Am Cd tlu&l1996;27:1486-90) 
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Cheyne-Stokes respiration during sleep is fol~im~l in patients 
with severe congestive heart failure (1). It induces repetitive 
oxygen cleduration and impairs sleep through arousals (2-5). 
IWlhubd sleep is likely to cause daytii symptoms and 
imp&d cognitive fmction Q-6). Repetitive oxygen desatu- 
ration and amrrsak cause an increase in sympathoneural 
rdvity as well as right and left ventricular afterbad (7-10). 
Aamdin&, sympatbotiettral activity has recently been dem- 
onstrated to he &zeased independently of left ven&icular 
Iimetii in pi&em with c?heyne-stoks respiratioo (5). ln- 
creased sy7npaW activity as well as right and left 
veotri&ar afterload are lily to be related to impaired 
exercise tokrance and prognosis in patients with heart failure 
(H-14). Hence, effective treatment of Cbeyne-Stokes respira- 
tion might imprcw exercise tolerance in patients with amges- 
tivehealtfitilure.Tltereisevidencethatltoctumaloxygen 
rednces cheyne-stokes l.eaphb and improws skep (3). 
The aim of the present study was to determine the effect of 
nocturnal nasal oxygen on respiration, sleep, cognitive func- 
tion, daytime symptoms and exercise tolerance in patients with 
congestive heart failure and Cheyne-Stokes respiration. 
Methods 
St&jeets and protucul. AU patients with sevrre heart fail- 
ure admitted to the Department of Cardiology were candidates 
for the study. Patients under the age of 75 years were eligible 
if they met the following criteria: at least one episode of 
cardiac decompensation, ejection fraction 135%, stable con- 
dition on cardiac mediition and evidence of Cheyne-Stokes 
respira& by nocturnal recording of onnasal air Row, oxygen 
~suuratiott and respiratq effort. ExchGon criteria were myo- 
carditd infarction within 1 year of entry, significant olkStNctive 
luqgdiseaseasdefinedbyaforcedeHpiratoryvolumeinls/ 
forced vital capacity 45%, primary vaivuhu heart dii, 
GbiiedmaorevideroeofobstrudivesleepapneaTbestudy 
wasappwdbytbehcalethicscommittee,fnfomredwrittett 
amsentwasobtainedfrmriaupatierl& 
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order to keep their weight constant throughout the study. 
Nasal nocturnal oxygen and r:*om air were administered via 
nasal prongs with a flow rate of 4 liters/min for seven nights. 
Oxygen and room air were provided by four coded air com- 
pressors. The code was known only by the manufacturer of the 
compressors (Heinen & Lowenstein) and was released at the 
end of the data analysis. During the seventh night of either 
room air or oxygen, polysomnography was performed. The 
following morning the patients filled in two questionnaires, and 
the trail-making test was administered. Thz maximal bicycte 
exercise test was performed then. Compliance with therapy 
was monitored by reading hidden time clocks that counted the 
total I ramber of hours the compressors were switched on. 
PuiysntnnugraPby. As described previously (15) elec- 
trodes for an electroencephalogram (C3A2 and C4Al of the 
international 18-M) system), electrooculogram, electromyo- 
gram and electrocardiogram were set in place. Air flow over 
nom and mouth was recorded by thermistors, and thorax and 
abdominal wall motion was monitored by strain gauges. Arte- 
rial oxygen saturation was measured transcu~ on the 
tip of the index tinger by pulse oximetry (Micro span 304OG). 
Before recordmg, signals of thorax and abdomii wall motion 
had to be adequate ht different sleep positions During the 
entire night, the recordii was observed on a monitor, and 
amplification of signak was corrected when necessary. The 
data were stored on an optical disk by a commercially availabfe 
computer system (CNS sleep lab, 1OlM/AfvlPs). The polysom- 
nogram was visually analy7ed in 38-s epochs for sleep stages 
according to Rechtschatfen and Kales (16). Ventricular ar- 
rhythmias were also analyzed. Arousals WC:: scored according 
to standard criteria (17). Cheyne-Stokes respiration was con- 
sidered to be present when there were at least three regular 
cyclesofi ncrea&ganddecreasingair8owasweUasincreas- 
ing and decreasing thoracic and abdominal efforts. A hypopnea 
was defined as a fall in oronasal air flow over 50% of baseline 
for more than IO s. An apnea was defined as the absence of 
oronasal air Uow for the same period. Accordingly, Cheyne- 
Stokes respiration was class&d as Cheyne-Stokes respiration 
with hypopwa and Cheyne-!hkes respimtion with apnea. Ihe 
apnea-hypopnea index was defined as the total number of 
sleepingapneasandhypopneasdividedbythetotalsJeeptime 
inhoursObstntctiveandmixedapneaswerescoredifpresent. 
The average cycle period and the transit time between the 
in4xae in ventilatitm and the nadii in arterial oxygen satura- 
tion during Cheyne-Stokes respimtion was averaged over the 
whoienight.ForeverycycJetheminimalandmaximalarterial 
oxygen saturation were meammd.Tlremeanoxygendesatuta- 
tion during Cheyne-Stokes respiration was cafadated by sub- 
tra&ngtheformerfromthelatter.IIteamormtof,timethe 
arterialoxygensaturationwaslessthan9O%,comaedfor 
timeinbe4andtheavemgeheartmtethrarghoutthenight 
-compited 
stable. The patients were told to maintain a pedaling rate of55 
to 65 rpm. Work was increased by 25 W every 3 min to the 
point of exhaustion. The patients breathed room air through a 
mouthpiece connected to an occlusion valve. Expired gas was 
collected in a mixing chamber and was continuously sampled 
using oxygen (Servomex) and carbon dioxide (Leybold- 
Heraeus) analysers (Ergostar FG 90. Werner Gut AG J. ,Ven- 
tilation and gas concentration were averaged ayer 30 s. and 
from these values minute ventilation. the rate of oxygen 
uptake. the rate of carbon dioxide production. respiratory 
exchange ratio and oxygen uptake were derived. The overall 
slope of the ventilation/carbon dioxide production ratio was 
calculated by regression analysis using all values of minute 
ventilation and minute carbon dioxide excretion during exer- 
cise. Peak oxygen consumption and oxygen consumption at the 
crossing point (the point where the respiratory exchange ratio 
equals 1) was obtained (18). Oxygen consumption at the 
crossing point is slightly higher than oxygen constmrption at the 
anaerobic threshold but has the advantage of being identitied 
more reliablv (18). 
Leti ven&lar end-diastolic and ieft atrial diimeters were 
evaluated by echocardiiby from a left pamsternal view. 
Left ventricular ejection fraction at rest was determined by 
Tc-99m gated blood pool scintigraphy. Spirometry wa5 per- 
fornxx$ and vital capacity, forced expiratory volume in 1 s and 
dilTusionopacityforca~~aregivenaspercent 
predicted (19). Minute ventilation and end-tidal carbon dii- 
ide pressure at rest were also evaluated (15). 
Sywtptom a.smmeA Patiints were asked to fill in a sleep 
questionnaire (SF-A). This questiomtaire asked them to esti- 
mate sleep bteny. number of awakenings and daytime sfeep- 
ines as well as mood when going to bed (20). In order to 
measure ftmctional consequences of dii, the Dartmouth 
COOP Ftmctional Health Assessment Charts were used (21). 
Thesechartsconsistofsingle-itemscafes,eachrepmsentinga 
differentdomainofftm&nalabili~pbysicdfitness,mood, 
dailyactivities,sncialacth&s,chaogeinbeahhandoveraR 
health. Both questmnnaims were administered bet& the 
studyandtheendofeachweekinthemoming.Jnfommtion 
speed~asameasureofc@tivefumXionwas 
evaluatedbythet~-malriagtestAudB(~)~ttheend 
eachweek. 
Ah vari&es were tested for nonnat 
aregivenasmean-csta4hd- 
fornormafd&ribotionandasmedian(range)ifnotnormaRy 
&libUtwi-lbercsultsf4W~dWOlDtiW~COt4l- 
paredwitlt*pairedStudentr-testforommal~ 
andtrytt+iredWfkoxontestifnntnonnaPydisMumd. 
Two-ta&~testswereused.ForanonmJd&r&Mkmthe 
personalonnpnterusingthestaMcaJpackngeN(SSfNurml 
her-- Sr 1989. by 1.1 
4iidhsL 
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‘It&k 1. Data of the 22 patients 
be0 59 (B-71) 
i30dytaamindex(k@tt2) 24.9 t 4.2 
Left.arialdfaamter(mm) 51 T.5 
lefts.&riaweod-baadifdiataeter(alm) 73 + 6 
LeRs-L+hdaepdicnm(%) 17(11-35) 
vdc;lpadtu(%p 792 16 
Fotdexpimtqwlwteia1s(%predicted) Xl 222 
Lmgtmsferfactorfixcdmmmmxide(%predtied) 79 + 23 
&ta pmmed are mediaa (ma& or mean value ?I SD. 
Results 
Three patients in the room air group and two patients in the 
oxygen group withdrew from the study because of the incon- 
venience of the nasal prongs. The data on the remaining 22 
patients are given in Table 1. Four patients had coronary artery 
disase., and 18 had idiopathic di!ated cardiomypathy with 
seyerehl m left ventricular function (Table 1). 
‘IhreewereinNewYorfrHeartAsociationciassII,and19in 
&ss III. Two patients exhibited atrial fibrillation, and one 
patient was female. One patient had a cerebral infaxtion 1 
year earlier. lwBdicatiors eoriskted of a diuretic in 21 patienh 
au t3q@ea&-cooverting enzyme inhibitor in 20 patien& 
beta-ae&yIdi@ iu 19 patients and a vasi&uor in 9 pa- 
~~No~in~ofthesemedicationsweremadefor 
the duration of the study. The patients showed slit restrictive 
vent&tory defects (Table 1). Lhuing the first week of the 
study, l2 patients received room air, ad 10 patients oxygen. 
b&auruntimeoftheamcentratoswas7.1 t 15h/daywith 
mom air and 73 t 1.2 h/day with oxygen (p = 0.16). Twu 
patientsineacsofthetwotreatmentgKlupsgainealmore~~ 
1 kg body weight as a result of fluid retention. The weight of 
tht3OthETjX&Bl8remaioedstable.ThebasalOxygenSatu~- 
tim1during8leepwas92.5 + 15%withroomairand%.3 2 
1.1% with oxygen treatment (p < O.OooOl). The avemge heart 
Rltedl&gtben@ltdWredWdfrom71r14/minto68-e 
wmindmiog tlatmeut (p < 0.02). 
patients suffered from Cheyne- 
deep (median 131, range 6 to 
oxygen .signhntly redueed the duration 
~~~*~~~t~~~~~~l). 
Inlwctpatieil&bothofwhomgainedweightdmingthestudy, 
tke~wman0 in the duratiou of cheyne-Stokes 
withtxyger8(Fii1).OxygenWurationduringthe 
iucnWedmtulremy(T~2).steepinipnwed,ils~ 
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Table 2. Effects of Nocturnal Oxygen on Chqne-Stokes Respiration 
and Sleep 
P 
Room Air Oxygen VplW 
Duration of CSR (% TS’I’) 33 (I-230) 10 (O-118) < 0.005 
Duration of CSR with apnea 7(0--211) 0 (O-l 18) 0.12 
(%TST) 
Apnea-hypopnea index (/h) 26 t 24 10 + 9 < 0.001 
Mean desaturatbn during oxygen 10 i 6 324 c o.OoOO1 
CSR (%) 
Percent of time in bed with 14.3 (0.1-6-q 0.1 (O-21) < o.wa3 
sao, < Kl?k 
Duratilm of a cycle Puiod 682 19 97t2-2 ‘c O.fxOOl 
Tic in bed (tin) 439 _f m 422270 0.68 
f otal sleep time (min) 346A86 343556 0.85 
Wake (96 the in bed) 18 + 16 17 2 10 0.75 
stasel(%rn 35 % 24 21 + 13 < o.lio1 
stase2@Tsr) 46 + 21 562 12 OK21 
*-*@TsT) 05 (O-15) 2.1 (O-22) 0.028 
REMdeep(%Tso 17 2 8 1859 0.41 
Amusk m 20213 15 2 9 0.025 
Data preseoted are mean value 2 SD or median (ran@). CSR = chqloe- 
St&srqimtiion;REM=mPideye movement; sat+ = arterial oxygen 
satmation; TST = total sleep time. 
and showed a correlation with the duration of Cheyne-Stokes 
respiration (r = -0.64, p < 0.01) and the percent of time in 
bed spent with an oxygen saturation <90% (rs = -0.45; p < 
0.05) but not with the left ventricular ejection fraction (rs = 
0.29; p = 0.16). There was an increase in peak oxygen 
consumption following oxygen treatment (Table 3). There was 
a correlation between the increase in peak oxygen WnSmnp- 
tion and the decrease in Chfyne-Stokes respiration (r = 0.45; 
_ p <’ 0.05), de decrease in arousals (r = 0.46; p < 0.05) as well 
as the decrease in percent of time in bed spent with an oxygen 
saturation <90% (r. = 0.35, p = 0.075) with oxygen treatment. 
In two patients, the crossing point could not be derived 
because of the short exercise duration. In the remaining 
JACC Vol. 27. No. 6 
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T&k 3. Effects of Nocturnal Oxygen on Exercise Capacity 
P 
Rwm Air WP value 
peak hem rate (lxawmii) 1lbr 13 112 t 15 0.46 
PeakdiWtiibklodpeswe(mmHg) 82 f 7 79-n 0.85 
-W~pr-(~W 13s + 18 1362 17 0.97 
Peak oxygen c@amplh (ml/inii) 835 2 3% y60+389 0.048 
aygen cmlsumption ,zasing point 642 2 210 741 r 223 0.0 IO 
(mUmin) 
Duration of exercise (min) 5.2 I 3.6 6.1 2 3.6 om4 
Ventilation/&n dimi& prcdti 402 13 382 12 O.Ol? 
ratio 
Gas exclrange Iado 1.1 I&? I.1 r 0.2 0.64 
Data presented are mean v&w f SD. 
patients a higher oxygen consumption at the crossing point was 
found following oxygen treatment (Table 3). 
During quiet breathing at rest, minute ventilation and 
end-tidal carbon diixide pressure were 15.3 2 3.6 liter&in 
and 33 C 6 mm Hg, respectively, and did not significantly 
change with oxygen treatment. 
Symptnm assessment. Awakenings estimated by the sleep 
ques6onnaire were higher than the normal range and were not 
reducedwithoaygentherapy.Sleeplatency,daytimeskep&ssas 
well as mood when going to bed were still in the normal range 
and dii not show an improvement with oxygen as compared to 
room air. Functional status evaluated by the Health Assess- 
ment Charts did not improve with oxygen. There was an improve- 
ment in the trail-making test A and B time with oxygen treatment 
41 (27 to 390) (median and range) vetsus 38 (22 to 110) s 
(p < 0.02) and !?7 (31 to 815) versus 90 (31 to 765). (p = 027). 
Discussion 
Pnfysnmnngmpby. Oxygen improved Cheyne-Stokes respi- 
ration and sleep in our patients (Tabfe 2). This is in keeping 
wtth the findings of Hanly and colleagues (3), who adminii 
tered nocturnal oxygen for one night in a randomizrd. single- 
blird, placebo-controlled xmssover study. They reported a 
reduction of Cbeyne-Stokes respiration, arousak and stage I 
sleep in the patients who were given oxygen. Our study extends 
these findings in that we found an increase in stage 2 and 
slow-wave sleep (Table 2). Arousak often o(rur during the 
hyperpneic phase of Cbeyne-Stokes respiration (4) and were 
therefore rednced with mxhnnal orygen. Brat the improve- 
ment in the amusals is related to the reduction in Cbeyne- 
Slakes respiration may be inferred by tbe correlations between 
tbechangesinthetwopiwamlers. 
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cl& disturbance of ventilation and respiratory control caused 
by arousals (2,24) and a relatively high hypercapnic ventilatory 
response (1524). Simihu to periodic respiration at high ahi- 
tudes. these mechanisms lead to an oscillation of the ventila- 
tory feedtiack loop controlling respiration. In the present 
study. nocturnal nasal oxygen increased the nocturnal oitygen 
saturation (Table 2) and probably the arterial carbon dioxide 
partial pressure. Therefore, oxygen is likely to reduce Cbeyne- 
Stokes respiration by a combinarion of the following mecha- 
nisms. It increases oxygen and carbon dioxide stores, mainly in 
the lung, and reduces the hypercapoic ventilatory response, 
thereby dampening the respiratory control system (3.24). Fur- 
ther oxygen is likely to cause an increase in the arterial carbon 
dioxide concentration near to, or above, the apneic threshold. 
The increased duration of a cycle period with oxygen treatment 
(Table 2) might be explained by the delayed and dampened 
response of the respiratory control system to hypercapnia with 
higher arterial oxygen saturation (25). Because the duration of 
apnea increased over IO s in some patients, the reduction of 
Cheyne-Stokes respiration with apnea did not reach statistical 
significance (Table 2). 
ICxedse test. Our results shanr an increase in peak oxygen 
consumption during bicycle exercise following oxygen therapy 
(Table 3). That improved sleep alone enables tbe patients to 
exercke harder is unlikely because the oxygen consumption at 
the crossing point and the ventilation/carbon dioxide produc- 
tion ratio (which are less influenced by patient motivation) 
were also increased with oxygen therapy It is also unlikely that 
the higher exercise tolerance results from a more tiiw life 
styfe with positive effects on circulation and peripheral mus- 
cies,hecauseratingofdailyandsosialxtMiesinthehealth 
assesmxnt &art dii not change with :reatment. Peak oxygen 
consumption after room air was negatively related to the 
duration of Uteyne-Stokes respiration and nocturnal oxygen 
saturation. Tbere was ako a correlation between the increare 
in peak oxygen consumption fohouing oxygen therapy and the 
improvement in Cbeyne-Stokes respimtion, arousak and We- 
tumal oxygen saturation following tberdpy. This sugges& that 
tbe imprnvetnent of Cheyne-Stokes respiration with concomi- 
tant reduction of arousab and improvement of oxygen satura- 
tion might be the cause for tbe @rovement of eaercise 
tderance folfowing treatment in onr patients. Peak oxygen 
ccmwn~irastrongprediiorofmortaliiinptkntsnrith 
heart faihrre (26.27), and therefore it can be- speculated that 
long-tewnccturnafoxygen~~slirvivaL 
fQnxemiacauxsanincreaseinpdwonacyartetypressure 
bypulmonary -iCentralapneasweresbuwnto 
heiitenkftandrightatrialprl?slmasweUaspldnlmmry 
ariery and systemic bkmd psqsure (7.9). la omnal taabjea 
tbeelevatmods+rnicbbodpresmredutirtgobstnrdive 
apilmswasdcterminedlargeIybyhypoaemia(B)-Ratsex- 
pssedtoepkadichyplidafoi7Ndaydispl;iyedaItrh 
~~mcansystemkbbodpessureandkftwttricb 
bypertrophy folbvhrg the v w). r3lpoxia hnmap 
niaaswdasaItmsakk~nmsckBarvc 
i 
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Increased sympathetic nerve activity and other markers of 
sympatlmtic system activation are present in heart failure and 
are related to impaired exercise tolerance and mortality in 
these patients (l&12). Similar right ventricular dysfunction, 
which may be induced by increased right ventricular afterload, 
is related to impaired exercise tolerance and survival (14). Such 
evidemx has Ied us to believe that Cheyne-Stokes respiration with 
hypoxemia hypercapnia and amttsak is likely to impede left 
vetltricuIar limctio~ exerck toIerance and survival. Reversal of 
Cheyne4toIres respiration hy oxygen treatment reduces right and 
left ventricuku afterload as well as sympathetic nerve activity 
and might thereby impmve exercise tolerance. The decrease in 
average heart rate with nocturnal oxygen in our patients is in 
agreement with a reduction in sympathetic nerve actbity; a 
reduction in the work of breathing may also play a role. 
Cbinunus positive airway pressure during sleep erJiihits 
positive effects on left ventricular perfo;mance in patients with 
heart failure and ~Geyne-Stokes respiration (2J). Similar to 
the above mentioned cnnsiderations, these tinclmgs are sug- 
gested to he related to changes in the autorurmic nervous 
system as evaluated by heart rate variability (3Q) and norepi- 
ne-phrine concentraticm (5). However, other studies showed no 
improvement in sleeping respiration, sleep or exercise toler- 
ance in patients with heart failure and Cheyne-Stokes respira- 
tion wceiving positive airway pressure (3132). 
Syruptrim assessment. Cognitive function improved in our 
patients follnwing nocturnal oxygen as evidenced hy the results 
of the trail-making test. Sin&u results have been reported with 
SUCCeSSN treatment of obstructive sleep apnea syndrome (6). 
ThatwedidnotIindasi&icantimptwementindaytime 
symRtums and mood with oxygen treatment might he explained 
hy the presence of severe heart failure causing marked daytime 
symptoms that can not be expected to be am&rated by 
impmved sleep. A known dbcrepancy of subjective and objec- 
tive daytime sympbmx may also play a role in patients with 
cheynestokes respiration (33). 
The dinical implicatbns of the presented tindii rest on 
the pntentiaI of nocturnal oxygen to improve s&p, exercise 
tolerance and cognitive function by reducing Cheyne-Stokes 
mspimtion in patients with severe congestive heart failure. 
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